244 related articles for article (PubMed ID: 23165827)
1. Successful treatment of bullous pemphigoid with omalizumab.
London VA; Kim GH; Fairley JA; Woodley DT
Arch Dermatol; 2012 Nov; 148(11):1241-3. PubMed ID: 23165827
[No Abstract] [Full Text] [Related]
2. Successful management of severe infant bullous pemphigoid with omalizumab.
Dufour C; Souillet AL; Chaneliere C; Jouen F; Bodemer C; Jullien D; Cambazard F; Joly P; Reix P
Br J Dermatol; 2012 May; 166(5):1140-2. PubMed ID: 22098309
[No Abstract] [Full Text] [Related]
3. Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab.
Fairley JA; Baum CL; Brandt DS; Messingham KA
J Allergy Clin Immunol; 2009 Mar; 123(3):704-5. PubMed ID: 19152970
[No Abstract] [Full Text] [Related]
4. Omalizumab therapy for bullous pemphigoid.
Yu KK; Crew AB; Messingham KA; Fairley JA; Woodley DT
J Am Acad Dermatol; 2014 Sep; 71(3):468-74. PubMed ID: 24954907
[TBL] [Abstract][Full Text] [Related]
5. Commentary: Omalizumab therapy for bullous pemphigoid by KK Yu, AB Crew, KAN Messingham, JA Fairley, DT Woodley. J Am Acad Dermatol 2014 Jun 20. pii: S0190-9622(14)01410-8. doi: 10.1016/j.jaad.2014.04.053. [Epub ahead of print].
Yancey KB
Dermatol Ther; 2015; 28(1):3. PubMed ID: 25286315
[No Abstract] [Full Text] [Related]
6. Anti-IgE monoclonal antibody (omalizumab) is effective in treating bullous pemphigoid and its effects on soluble CD200.
Yalcin AD; Genc GE; Celik B; Gumuslu S
Clin Lab; 2014; 60(3):523-4. PubMed ID: 24697134
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab for the treatment of atopic dermatitis.
Fernández-Antón Martínez MC; Leis-Dosil V; Alfageme-Roldán F; Paravisini A; Sánchez-Ramón S; Suárez Fernández R
Actas Dermosifiliogr; 2012 Sep; 103(7):624-8. PubMed ID: 22056257
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report.
Vico-Alonso C; Calleja-Algarra A; Aragón-Miguel R; Sánchez-Velázquez A; Velasco-Tamariz V; Ortiz-Romero PL; Monsálvez-Honrubia V
Dermatol Ther; 2019 Mar; 32(2):e12829. PubMed ID: 30659716
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid.
Seyed Jafari SM; Feldmeyer L; Bossart S; Simon D; Schlapbach C; Borradori L
Front Immunol; 2020; 11():611549. PubMed ID: 33584689
[TBL] [Abstract][Full Text] [Related]
10. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
Ikeda T; Okamoto K; Furukawa F
J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
[No Abstract] [Full Text] [Related]
11. Aspirin tolerance following omalizumab therapy in a patient with aspirin-exacerbated respiratory disease.
Aksu K; Kurt E
Allergol Immunopathol (Madr); 2013; 41(3):208-10. PubMed ID: 22763305
[No Abstract] [Full Text] [Related]
12. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.
Ojaimi S; Harnett PR; Fulcher DA
J Allergy Clin Immunol Pract; 2014; 2(1):105-6. PubMed ID: 24565780
[No Abstract] [Full Text] [Related]
13. Successful treatment of a bullous urticaria with omalizumab.
Ozturk AB; Kocaturk E; Ozturk E
Allergol Int; 2014 Sep; 63(3):495-7. PubMed ID: 24957115
[No Abstract] [Full Text] [Related]
14. High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.
Busse W; Spector S; Rosén K; Wang Y; Alpan O
J Allergy Clin Immunol; 2013 Aug; 132(2):485-6.e11. PubMed ID: 23591271
[No Abstract] [Full Text] [Related]
15. Anti-laminin γ1 pemphigoid.
Kalkoff EC; Bramsiepe I; Groth S; Marsch WC; Kreft B
J Dtsch Dermatol Ges; 2013 Jun; 11(6):555-7. PubMed ID: 23480370
[No Abstract] [Full Text] [Related]
16. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
Wolf BL; Johnson A
J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
[No Abstract] [Full Text] [Related]
17. A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis.
Wang G; Hu X; Han S; Zhou M
J Dermatolog Treat; 2024 Dec; 35(1):2366535. PubMed ID: 38945532
[No Abstract] [Full Text] [Related]
18. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
[No Abstract] [Full Text] [Related]
19. The anti-IgE antibody omalizumab as a probe to investigate the role of IgE in pathology.
Mauro M; Incorvaia C; Formigoni C; Elia R; Russello M; Pellegrino D
Panminerva Med; 2012 Dec; 54(4):305-12. PubMed ID: 23123583
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune bullous eruption localized to a breast reconstruction site: response to niacinamide.
Honl BA; Elston DM
Cutis; 1998 Aug; 62(2):85-6. PubMed ID: 9714904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
